Pharmacoeconomic Analysis of the Inclusion of Rivaroxaban in the Current Algorithms Prevention of the Stroke in Patients With Atrial Fibrillation

被引：0
|
作者：
Kulikov, A. Yu. [1 ]
Protsenko, M. V. [1 ]
Serdechnaya, E. V. [2 ]
机构：
[1] Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Northern State Med Univ, Arkhangelsk, Russia
来源：
KARDIOLOGIYA | 2016年 / 56卷 / 11期
关键词：
ANTICOAGULATION;
D O I：
10.18565/cardio.2016.11.71-77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：71 / 77
页数：7
相关论文
共 50 条
  • [41] A PHARMACOECONOMIC ANALYSIS OF THE USE OF APIXABAN FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN RUSSIAN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Ryazhenov, V. V.
    Gorokhova, S. G.
    Gorokhov, V
    VALUE IN HEALTH, 2018, 21 : S99 - S99
  • [42] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Wang, Ye
    Xie, Feng
    Kong, Ming Chai
    Lee, Lai Heng
    Ng, Heng Joo
    Ko, Yu
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (06) : 575 - 585
  • [43] Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation
    Ye Wang
    Feng Xie
    Ming Chai Kong
    Lai Heng Lee
    Heng Joo Ng
    Yu Ko
    Cardiovascular Drugs and Therapy, 2014, 28 : 575 - 585
  • [44] Efficacy, safety and tolerability of rivaroxaban for the secondary prevention of stroke in patients with atrial fibrillation in clinical practice
    Monteagudo, Maria
    Fernandez-Diaz, Eva
    Garcia-Garcia, Jorge
    Ayo-Martin, Oscar
    Hernandez-Fernandez, Francisco
    Segura, Tomas
    FUTURE NEUROLOGY, 2015, 10 (06) : 529 - 536
  • [45] Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    CIRCULATION, 2016, 133 (04) : 352 - 360
  • [46] Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation
    Szekely, Orsolya
    Miyazawa, Kazuo
    Lip, Gregory Yoke Hong
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 1999 - 2009
  • [47] Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
    Hohnloser, Stefan H.
    Duray, Gabor Z.
    Baber, Usman
    Halperin, Jonathan L.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0H) : H4 - H10
  • [48] Survey of current clinical practice in stroke prevention in patients with atrial fibrillation
    Sanyal, R.
    Muddegowda, G.
    Natarajan, I
    Chembala, J.
    Roffe, C.
    INTERNATIONAL JOURNAL OF STROKE, 2013, 8 : 24 - 24
  • [49] Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation
    Antoniou, Sotiris
    Amara, Walid
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0D) : D7 - D15
  • [50] Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation An Instrumental Variable Analysis of a Nationwide Cohort
    Bonde, Anders N.
    Martinussen, Torben
    Lee, Christina J. -Y.
    Lip, Gregory Y. H.
    Staerk, Laila
    Bang, Casper N.
    Bhattacharya, Jay
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Olesen, Jonas Bjerring
    Hlatky, Mark A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (04): : 58 - 67
12345